{
  "first_published_at": "2009-05-01", 
  "original_url": "http://www.mhra.gov.uk/Safetyinformation/DrugSafetyUpdate/CON088004", 
  "title": "Non-steroidal anti-inflammatory drugs: reminder on renal failure and impairment", 
  "tags": "{\"parsed_therapeutic\": [\"pain-management-palliation\", \"rheumatology\", \"urology-nephrology\"], \"Audience:\": [\"Primary care\", \"Secondary care\"], \"Therapeutic area:\": [\"Pain management and palliation\", \"Rheumatology\", \"Urology and nephrology\"]}", 
  "_document_number": 263, 
  "label": null, 
  "icon": "http://www.mhra.gov.uk/home/images/MHRALook/img/dsu/adverse_icon.png", 
  "therapeutic_area": [
    "pain-management-palliation", 
    "rheumatology", 
    "urology-nephrology"
  ], 
  "raw_html": "<div id=\"dsuArticleContent\">\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t\t<h1><a name=\"maincontent\" id=\"maincontent\"></a>Non-steroidal anti-inflammatory drugs: reminder on renal failure and impairment</h1>\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t<span class=\"ref\">Article date: May 2009</span> \r\n\t\t\t\t\t\t\t\t<!--SS_BEGIN_ELEMENT(region1_element21)-->\r\n\t\t\t\t\t\t\t\t<!---->\r\n\t\t\t\t\t\t\t\t<!--SS_END_ELEMENT(region1_element21)-->\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t<!--SS_BEGIN_ELEMENT(region1_element22)-->\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t<!--SS_END_ELEMENT(region1_element22)-->\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t<div id=\"dsuSynopsis\" class=\"yellow\">\r\n\t\t\t\t\t\t\t\t\t<div class=\"dsuArticlePadding\">\r\n\t\t\t\t\t\t\t\t\t<span id=\"dsuSynopsisTitle\"><b>Summary</b></span>\t\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t\t<br>Caution should be exercised when using NSAIDs in patients with established, or a risk of, renal impairment<br>\t\r\n\t\t\t\t\t\t\t\t\t</div>         \t\t\r\n\t\t\t\t\t\t\t\t\t<div id=\"dsuSynopsisCut\">\r\n\t\t\t\t\t\t\t\t\t</div>\r\n\t\t\t\t\t\t\t\t</div>\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t<!--SS_BEGIN_ELEMENT(region1_element13)-->\r\n\t\t\t\t\t\t\t\t<!--<p>Non-steroidal anti-inflammatory drugs (NSAIDs, including COX-2 inhibitors) may rarely precipitate renal failure, and vulnerable (particularly elderly) patients may be at increased risk. NSAID use accounts for an estimated 15% of all cases of drug-induced acute renal failure.<cite>Delmas PD. Br J Rheumatol 1995; 34 (suppl 1): 25&ndash;28.</cite> A case-control study estimated an increased relative risk (3&middot;2 [95% CI 1&middot;8&ndash;5&middot;8]) of acute renal failure in otherwise healthy current users of NSAIDs.<cite>Huerta C, et al. Am J Kidney Dis 2005; 45: 531&ndash;39.</cite></p><p>We continue to receive case reports of renal failure in NSAID users. Prescribing information for NSAIDs includes warnings about renal impairment and renal failure, and advises that the risk of renal failure is highest in those with existing renal impairment.</p><p>In patients with conditions that cause renal hypoperfusion, prostaglandin production may be increased to maintain adequate renal blood flow. The adverse renal effects associated with NSAIDs are mainly mediated via inhibition of prostaglandin-induced vasodilation and can result in reduced renal blood flow. Patients with conditions such as hypovolaemia, congestive heart failure, liver cirrhosis, or multiple myeloma are at particular risk. Contributing risk factors include the current administration of medicines such as angiotensin converting enzyme (ACE) inhibitors, angiotensin II receptors antagonists, and diuretics.</p><p>NSAIDs may also produce direct toxic effects on the kidney. The main mechanisms for acute renal failure include acute tubular necrosis and acute interstitial nephritis. Other rarer mechanisms have also been reported, such as acute papillary necrosis and renal vasculitis. Adverse renal effects are generally reversible on discontinuation of NSAID treatment.</p><div class=\"dull_highlight\">\r\n\t\t\t<p><strong>Advice for healthcare professionals:</strong></p>\r\n\t\t\t<ul>\r\n\t\t\t\t<li>Patients at risk of renal impairment or renal failure (particularly elderly people) should avoid NSAIDs if possible. If NSAID treatment is absolutely necessary, then the lowest effective dose for the shortest possible duration should be used to control symptoms. The renal function of such patients should be carefully monitored during NSAID treatment</li>\r\n\t\t\t\t<li>It is important to consider other concomitant disease states, conditions, or medicines that may precipitate reduced renal function when prescribing NSAIDs</li>\r\n\t\t\t</ul></div><p>&nbsp;</p><p><em>Article citation: Drug Safety Update May 2009, vol 2 issue 10: 4.</em></p>-->\r\n\t\t\t\t\t\t\t\t<!--SS_END_ELEMENT(region1_element13)-->\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\t<!-- SS_BEGIN_SNIPPET(fragment7,1)-->\r\n\t\t\t\t\t\t\t\t<!-- call include to dynamically insert alt attributes into image tags within a wysiwyg element -->\r\n<!-- get a reference to the wysiwyg content -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n\t<p>Non-steroidal anti-inflammatory drugs (NSAIDs, including COX-2 inhibitors) may rarely precipitate renal failure, and vulnerable (particularly elderly) patients may be at increased risk. NSAID use accounts for an estimated 15% of all cases of drug-induced acute renal failure.<cite>Delmas PD. Br J Rheumatol 1995; 34 (suppl 1): 25&#8211;28.</cite> A case-control study estimated an increased relative risk (3&#183;2 [95% CI 1&#183;8&#8211;5&#183;8]) of acute renal failure in otherwise healthy current users of NSAIDs.<cite>Huerta C, et al. Am J Kidney Dis 2005; 45: 531&#8211;39.</cite></p><p>We continue to receive case reports of renal failure in NSAID users. Prescribing information for NSAIDs includes warnings about renal impairment and renal failure, and advises that the risk of renal failure is highest in those with existing renal impairment.</p><p>In patients with conditions that cause renal hypoperfusion, prostaglandin production may be increased to maintain adequate renal blood flow. The adverse renal effects associated with NSAIDs are mainly mediated via inhibition of prostaglandin-induced vasodilation and can result in reduced renal blood flow. Patients with conditions such as hypovolaemia, congestive heart failure, liver cirrhosis, or multiple myeloma are at particular risk. Contributing risk factors include the current administration of medicines such as angiotensin converting enzyme (ACE) inhibitors, angiotensin II receptors antagonists, and diuretics.</p><p>NSAIDs may also produce direct toxic effects on the kidney. The main mechanisms for acute renal failure include acute tubular necrosis and acute interstitial nephritis. Other rarer mechanisms have also been reported, such as acute papillary necrosis and renal vasculitis. Adverse renal effects are generally reversible on discontinuation of NSAID treatment.</p><div class=\"dull_highlight\">\r\n\t\t\t<p><strong>Advice for healthcare professionals:</strong></p>\r\n\t\t\t<ul>\r\n\t\t\t\t<li>Patients at risk of renal impairment or renal failure (particularly elderly people) should avoid NSAIDs if possible. If NSAID treatment is absolutely necessary, then the lowest effective dose for the shortest possible duration should be used to control symptoms. The renal function of such patients should be carefully monitored during NSAID treatment</li>\r\n\t\t\t\t<li>It is important to consider other concomitant disease states, conditions, or medicines that may precipitate reduced renal function when prescribing NSAIDs</li>\r\n\t\t\t</ul></div><p>&#160;</p><p><em>Article citation: Drug Safety Update May 2009, vol 2 issue 10: 4.</em></p>\r\n\t\t\t\r\n\t\t\t\t\t\t\t\t<!-- SS_END_SNIPPET(fragment7,1)-->\r\n\t\t\t\t\t\t\t</div>\r\n\t\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t", 
  "date_of_article": "2009-05-01", 
  "date_last_modified": "2010-08-17", 
  "_assets": [], 
  "_item_id": 263, 
  "summary": "Caution should be exercised when using NSAIDs in patients with established, or a risk of, renal impairment", 
  "body": "Article date: May 2009\n\nNon-steroidal anti-inflammatory drugs (NSAIDs, including COX-2 inhibitors) may rarely precipitate renal failure, and vulnerable (particularly elderly) patients may be at increased risk. NSAID use accounts for an estimated 15% of all cases of drug-induced acute renal failure.[^1] A case-control study estimated an increased relative risk (3·2 [95% CI 1·8–5·8]) of acute renal failure in otherwise healthy current users of NSAIDs. [^2]\n\nWe continue to receive case reports of renal failure in NSAID users. Prescribing information for NSAIDs includes warnings about renal impairment and renal failure, and advises that the risk of renal failure is highest in those with existing renal impairment.\n\nIn patients with conditions that cause renal hypoperfusion, prostaglandin production may be increased to maintain adequate renal blood flow. The adverse renal effects associated with NSAIDs are mainly mediated via inhibition of prostaglandin-induced vasodilation and can result in reduced renal blood flow. Patients with conditions such as hypovolaemia, congestive heart failure, liver cirrhosis, or multiple myeloma are at particular risk. Contributing risk factors include the current administration of medicines such as angiotensin converting enzyme (ACE) inhibitors, angiotensin II receptors antagonists, and diuretics.\n\nNSAIDs may also produce direct toxic effects on the kidney. The main mechanisms for acute renal failure include acute tubular necrosis and acute interstitial nephritis. Other rarer mechanisms have also been reported, such as acute papillary necrosis and renal vasculitis. Adverse renal effects are generally reversible on discontinuation of NSAID treatment.\n\nAdvice for healthcare professionals:  \n  \n  * Patients at risk of renal impairment or renal failure (particularly elderly people) should avoid NSAIDs if possible. If NSAID treatment is absolutely necessary, then the lowest effective dose for the shortest possible duration should be used to control symptoms. The renal function of such patients should be carefully monitored during NSAID treatment  \n  * It is important to consider other concomitant disease states, conditions, or medicines that may precipitate reduced renal function when prescribing NSAIDs  \n  \n \n\nArticle citation: Drug Safety Update May 2009, vol 2 issue 10: 4.\n\n[^1]: Delmas PD. Br J Rheumatol 1995; 34 (suppl 1): 25–28.\n\n[^2]: Huerta C, et al. Am J Kidney Dis 2005; 45: 531–39.\n"
}